Andrew Schwartz, Founder of the Qualitas Group
An interview with Andrew Schwartz, Group Managing Director and Chief Investment Officer of Qualitas.
Copyright 2020 – Finance News Network
Source: Finance News Network
An interview with Andrew Schwartz, Group Managing Director and Chief Investment Officer of Qualitas.
Copyright 2020 – Finance News Network
Source: Finance News Network
20 Sep 2019 - Aus Tin Mining Limited (ASX:ANW) CEO, Peter Williams talks about major developments at both the Granville and Taronga projects.
Read More13 Dec 2023 - Chilwa Minerals Limited (ASX:CHW) Managing Director Cadell Buss discusses surprising drilling results and outlines future exploration plans.
Read More30 Jul 2021 - Novatti Group Limited (ASX:NOV) CEO, Peter Cook, provides an update on activities from the company's June quarter, discussing growth in platforms and infrastructure and the recent capital raise.
Read More07 Aug 2020 - Australian Banking Association CEO, Anna Bligh discusses how the banking sector is responding to COVID-19 and what customers can expect from the new banking code.
Read More03 Nov 2023 - NOVONIX (ASX:NVX) CEO, Chris Burns, discusses securing a $100 million grant from the DOE, the company's Riverside facility expansion, graphite's future amidst China's export controls, and the pivotal role of synthetic graphite in clean energy.
Read More17 Feb 2023 - Radiopharm Theranostics Limited (ASX:RAD) CEO and Managing Director Riccardo Canevari discusses the company's upcoming plans to list on the NASDAQ and provides an update on the its clinical trials.
Read More25 Feb 2020 - Noxopharm Limited (ASX:NOX) Chief Medical Officer, Dr Gisela Mautner, talks about results from the company's LuPIN trial in prostate cancer, evaluating its lead product candidate, Veyonda, in combination with 177Lu-PSMA-617, a radiopharmaceutical therapy, in 56 patients with late-stage prostate cancer.
Read More01 Jun 2020 - OncoSil Medical Limited (ASX:OSL) Managing Director and CEO Daniel Kenny talks about the significance of the company's CE Marking approval for its lead product OncoSil, which helps treat pancreatic, liver and biliary duct cancer.
Read More16 Sep 2024 - Quantum Brilliance CEO Mark Luo discusses how his company is pioneering quantum computing with synthetic diamonds, offering a miniaturised and energy-efficient alternative. He highlights the company's rapid growth since its spin-out from the Australian National University, its unique approach to quantum technology and the enormous commercial potential of quantum at the edge.
Read More18 Apr 2024 - Anax Metals (ASX:ANX) CEO Geoff Laing discusses the company's innovative approach to mining as its pioneers bioleaching tech for sustainable resource extraction.
Read More